Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 257-262

  Tropé, Ameli ^a   Jonassen, Christine M ^a   Sjøborg, Katrine D ^b   Nygård, Mari ^c   Dahl, Fredrik A ^a   Alfsen, G Cecilie ^a   Lie, A Kathrine ^d  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b Oestfold Hospital Trust   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

DNA; Follow up; High grade cervical neoplasia; HPV test; mRNA; Residual

Indexed keywords

MESSENGER RNA; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; RISK; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 81155160134     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.032     Document Type: Article

References (29)

1. A.G. Ostor Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12 1993 186 192
2. M.R. McCredie, K.J. Sharples, C. Paul, J. Baranyai, G. Medley, and R.W. Jones Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncol 9 2008 425 434
3. E. Paraskevaidis, G. Koliopoulos, V. Malamou-Mitsi, K. Zikopoulos, M. Paschopoulos, and L. Pappa Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience Anticancer Res 21 2001 3097 3099
4. M. Arbyn, P. Sasieni, C.J. Meijer, C. Clavel, G. Koliopoulos, and J. Dillner Chapter 9: clinical applications of HPV testing: a summary of meta-analyses Vaccine 24 Suppl. 3 2006 89
5. E. Paraskevaidis, L. Jandial, E.M.F. Mann, P.M. Fisher, and H.C. Kitchener Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol Obstet Gynecol 78 1991 80 83
6. Veileder i gynekologisk onkologi. Norwegian Gynecological Oncology Guidelines http://www.legeforeningen.no/id/153773.0 2009
7. J.H. Bae, C.J. Kim, T.C. Park, S.E. Namkoong, and J.S. Park Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure Int J Gynecol Cancer 17 2007 1271 1277
8. E. Paraskevaidis, G. Koliopoulos, Y. Alamanos, V. Malamou-Mitsi, E.D. Lolis, and H.C. Kitchener Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia Obstet Gynecol 98 2001 833 836
9. N.H. Jeong, N.W. Lee, H.J. Kim, T. Kim, and K.W. Lee High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia J Obstet Gynaecol Res 35 2009 706 711
10. C.B.J. Woodman, S.I. Collins, and L.S. Young The natural history of cervical HPV infection: unresolved issues Nat Rev Cancer 7 2007 11 22
11. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses 2008 IARC Press Lyon
12. G.D. Zielinski, A.G. Bais, T. Helmerhorst, R.H.M. Verheijen, F.A. De Schipper, and P.J.F. Snijders HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis Obstet Gynecol Surv 59 2004 543 553
13. G.D. Zielinski, L. Rozendaal, F.J. Voorhorst, J. Berkhof, P.J.F. Snijders, and E.J.K. Risse HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3 Gynecol Oncol 91 2003 67 73
14. I. Alonso, A. Torne, L.M. Puig-Tintore, R. Esteve, L. Quinto, and E. Campo Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3 Gynecol Oncol 103 2006 631 636
15. J. Verguts, B. Bronselaer, G. Donders, M. Arbyn, E.J. Van, and M. Drijkoningen Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation BJOG: Int J Obstet Gynaecol 113 2006 1303 1307
16. J. Doorbar Molecular biology of human papillomavirus infection and cervical cancer Clin Sci (Lond) 110 2006 525 541
17. S.K. Kjaer, A.J. van den Brule, G. Paull, E.I. Svare, M.E. Sherman, and B.L. Thomsen Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study BMJ 325 2002 572
18. A. Trope, K. Sjoborg, A. Eskild, K. Cuschieri, T. Eriksen, and S. Thoresen Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia J Clin Microbiol 47 2009 2458 2464
19. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, and M. Prey The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
20. A.K. Lie, B. Risberg, B. Borge, B. Sandstad, J. Delabie, and R. Rimala DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia Gynecol Oncol 97 2005 908 915
21. E.A. Burger, H. Kornr, M. Klemp, V. Lauvrak, and I.S. Kristiansen HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review Gynecol Oncol 120 2011 430 438
22. A. Szarewski, L. Ambroisine, L. Cadman, J. Austin, L. Ho, and G. Terry Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 2008 3033 3042
23. S. Ratnam, F. Coutlee, D. Fontaine, J. Bentley, N. Escott, and P. Ghatage Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer J Clin Microbiol 49 2011 557 564
24. P. Fuste, B. Bellosillo, X. Santamaria, G. Mancebo, L. Marinoso, and F. Alameda HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model Int J Gynecol Pathol 28 2009 120 126
25. J. Gallwas, N. Ditsch, P. Hillemanns, K. Friese, C. Thaler, and C. Dannecker The significance of HPV in the follow-up period after treatment for CIN Eur J Gynaecol Oncol 31 2010 27 30
26. S. Ghaem-Maghami, S. Sagi, G. Majeed, and W.P. Soutter Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis Lancet Oncol 8 2007 985 993
27. B. Strander, W. Ryd, K.L. Wallin, B. Warleby, B. Zheng, and I. Milsom Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer 43 2007 1849 1855
28. M. Kocken, T.J. Helmerhorst, J. Berkhof, J.A. Louwers, M.A. Nobbenhuis, and A.G. Bais Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study Lancet Oncol 12 2011 441 450
29. N. Munoz, X. Castellsague, A.B. de Gonzalez, and L. Gissmann Chapter 1: HPV in the etiology of human cancer Vaccine 24 2006 S1 S10